Biochemistry, Genetics and Molecular Biology
Cancer Cell
91%
Dynamics
42%
Quantitative Technique
42%
Overall Survival
42%
Histone Deacetylase 2
42%
Progression Free Survival
42%
Steady State
42%
Homeostasis
42%
Messenger RNA
42%
Chromatin Remodeling
42%
KEAP1
42%
Cisplatin
36%
Methylation
28%
Anticancer
28%
Pertuzumab
28%
Heterochromatin Protein 1
18%
DNA Damage Response
18%
Monoclonal Antibody
14%
Glutathione
14%
Promoter Region
14%
Proteomics
14%
Drug Resistance
14%
Trastuzumab
14%
Receptor Tyrosine Kinase
14%
Histone Deacetylase
6%
Small Interfering RNA
6%
PEO1
6%
Morphology
6%
Programmed Cell Death
6%
DNA Damage
6%
Cell Cycle
6%
Double-Strand DNA Break
6%
Medicine and Dentistry
Ovarian Cancer
100%
Overall Survival
42%
Cancer Prognosis
42%
Reactive Oxygen Species
42%
Tumor Xenograft
42%
Progression Free Survival
42%
Cancer Cell
42%
Carboplatin
42%
Antioxidant
42%
Phosphoprotein
42%
Malignant Neoplasm
18%
Paclitaxel
17%
Molecular Profiling
14%
Proteomics
14%
Proportional Hazards Model
14%
Tumor Histology
14%
Epithelial Mesenchymal Transition
12%
Neoplasm
8%
Xenograft
8%
Cell Cycle
8%
Steady State
6%
Homeostasis
6%
Cell Line
6%
Neuroscience
Carboplatin
55%
Histone Deacetylase 2
42%
Antioxidant
42%
Chromatin Assembly and Disassembly
42%
Reactive Oxygen Species
42%
Messenger RNA
42%
Phosphoprotein
42%
Cisplatin
36%
Heterochromatin Protein 1
18%
DNA Damage Response
18%
Cell Line
18%
Paclitaxel
17%
Cell Cycle
14%
Protein Expression
11%
In Vivo
10%
Small Interfering RNA
6%
DNA Damage
6%
Double Stranded DNA
6%
Histone Deacetylase
6%
Cell DNA
6%
In Vitro
6%
Programmed Cell Death
6%